Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: PRGO stock price vs NE: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at NE's multiple
Needs NE P/S.
Implied fair value · at PRGO's multiple
Needs PRGO P/S.
Metric by metric
Price unavailable
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: PRGO FY 2025 (ended Dec 31, 2025) · NE FY 2025 (ended Dec 31, 2025).
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Perrigo Company plc · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Noble Corporation plc · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
1.24x
0.43x
Net debt / EBITDA
Leverage against operating earnings
—
3.46x
Cash and equivalents
Liquid reserves on the balance sheet
—
$471.40M
Total debt
Interest-bearing obligations outstanding
$3.64B
$1.98B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
TEVA PHARMACEUTICAL INDUSTRIES LTD
PRGO vs TEVA
Organon & Co.
PRGO vs OGN
Hims & Hers Health, Inc.
PRGO vs HIMS
HERBALIFE LTD.
PRGO vs HLF
Transocean Ltd.
PRGO vs RIG
Valaris Ltd
PRGO vs VAL
Seadrill Ltd
PRGO vs SDRL
VALERO ENERGY CORP/TX
PRGO vs VLO
ONEOK INC /NEW/
PRGO vs OKE
HALLIBURTON CO
PRGO vs HAL
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
